abstract |
Providing target-directed DDS nanoparticles that accumulate in a target tissue such as an inflammatory site of an inflammatory disease and can be used as a drug delivery system (DDS) for treatment or diagnosis for locally delivering a drug or gene to an affected area. A pharmaceutical composition for treating or diagnosing inflammatory diseases, comprising a sugar chain-modified liposome in which a sugar chain is bound to a liposome membrane. |